BICLUSTER_ID : UPREG-124
PATHOGENS /3/ : listeria monocytogenes,streptococcus pneumoniae,yersinia enterocolitica
TARGETS /8/ : IL6, PTGS2, JUN, F3, PIM1, CD55, SERPINB2, PLAUR
Gene SetLeading Edge Genes
GERY CEBP TARGETSGADD45B, CXCL1, JUNB, KLF4, HBEGF, SERPINB2, GADD45G, ATF3, PIM1, PLAUR, DUSP1
NETPATH IL 1 PATHWAY UPNR4A3, LIF, CXCL1, HBEGF, SERPINB2, IL6, PTGS2, ZFP36, CXCL2
NETPATH EGFR1 PATHWAY UPEGR1, PTGS2, TNFAIP3, LIF, SERPINB2, PLAUR, DUSP1
NETPATH IL 2 PATHWAY UPKLF6, LIF, GADD45G, PMAIP1, SOCS3, ETS2, IL6, PIM1, PLAUR
NETPATH IL 4 PATHWAY UPSOCS3, IL6, MXD1, F3, ELL2
NETPATH IL 4 PATHWAY DOWNIL6, GADD45B, PTGS2, CXCL2
NCI LYSOPHOSPHOLIPID PATHWAYADCY8, IL6, JUN, EDG7, HBEGF
NETPATH TNF ALPHA PATHWAY DOWNKLF6, CXCL1, JUNB, TIPARP, MAFF, IL6, GEM, EGR1, DUSP2, PTGS2, TNFAIP3, ZFP36, CXCL2
NETPATH IL 3 PATHWAY UPNFIL3, SOCS3, PIM1, MYC
NETPATH IL 6 PATHWAY UPGADD45B, CXCL1, JUNB, HBEGF, MAP3K8, SOCS3, MAFF, ZFP36, PIM1
NETPATH IL 5 PATHWAY UPEGR1, CD55, MAPK6
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
MAHAJAN RESPONSE TO IL1A UP
LINDGREN BLADDER CANCER CLUSTER 2B
VANHARANTA UTERINE FIBROID DN
CHUANG OXIDATIVE STRESS RESPONSE UP
CHEN LVAD SUPPORT OF FAILING HEART UP
TENEDINI MEGAKARYOCYTE MARKERS
LINDSTEDT DENDRITIC CELL MATURATION B
RASHI RESPONSE TO IONIZING RADIATION 2
LINDSTEDT DENDRITIC CELL MATURATION A
BASAKI YBX1 TARGETS DN
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
ODONNELL TFRC TARGETS UP
ELVIDGE HYPOXIA UP
GRAHAM CML QUIESCENT VS NORMAL QUIESCENT DN
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
AMIT EGF RESPONSE 40 HELA
NETPATH IL 7 PATHWAY UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
MORI EMU MYC LYMPHOMA BY ONSET TIME DN
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
HINATA NFKB TARGETS KERATINOCYTE UP
DORN ADENOVIRUS INFECTION 48HR DN
GENTILE UV RESPONSE CLUSTER D1
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
AMIT EGF RESPONSE 240 MCF10A
OSADA ASCL1 TARGETS DN
AMIT SERUM RESPONSE 60 MCF10A
DUTTA APOPTOSIS VIA NFKB
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS MAGENTA UP
KRISHNAN FURIN TARGETS UP
DIRMEIER LMP1 RESPONSE EARLY
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN
SEMENZA HIF1 TARGETS
NCI NFAT TFPATHWAY
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLUE UP
SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN 2FC DN
AMIT EGF RESPONSE 120 HELA
DEBOSSCHER NFKB TARGETS REPRESSED BY GLUCOCORTICOIDS
BIOCARTA RANKL PATHWAY
VART KSHV INFECTION ANGIOGENIC MARKERS DN
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
WINTER HYPOXIA METAGENE
MCLACHLAN DENTAL CARIES UP
DAZARD RESPONSE TO UV NHEK UP
GAJATE RESPONSE TO TRABECTEDIN UP
NEWMAN ERCC6 TARGETS UP
SHAFFER IRF4 TARGETS IN PLASMA CELL VS MATURE B LYMPHOCYTE
PODAR RESPONSE TO ADAPHOSTIN UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE UP
FOSTER INFLAMMATORY RESPONSE LPS DN
LEE LIVER CANCER E2F1 UP
TAVOR CEBPA TARGETS UP
GAURNIER PSMD4 TARGETS
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
ZHOU INFLAMMATORY RESPONSE LPS UP
BOQUEST STEM CELL CULTURED VS FRESH DN
GESERICK TERT TARGETS DN
NETPATH TGFBETA RECEPTOR PATHWAY DOWN
AMIT SERUM RESPONSE 120 MCF10A
BROWNE HCMV INFECTION 2HR UP
DORN ADENOVIRUS INFECTION 24HR DN
ZIRN TRETINOIN RESPONSE UP
SESTO RESPONSE TO UV C3
VERHAAK AML WITH NPM1 MUTATED UP
AMIT EGF RESPONSE 40 MCF10A
BROCKE APOPTOSIS REVERSED BY IL6
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
NCI P53DOWNSTREAMPATHWAY
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX RPL6 RPL30 RPS13 CHUK DDX3X NFKB2 NFKBIB REL IKBKG NFKB1 MAP3K8 RELB GLG1 NFKBIA RELA TNIP2 GTF2I
ZHOU INFLAMMATORY RESPONSE FIMA UP
TIAN TNF SIGNALING VIA NFKB
NCI HIF2PATHWAY
MURAKAMI UV RESPONSE 1HR DN
GENTILE UV LOW DOSE UP
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
KRIGE AMINO ACID DEPRIVATION
AMIT EGF RESPONSE 60 MCF10A
HINATA NFKB TARGETS FIBROBLAST UP
RHEIN ALL GLUCOCORTICOID THERAPY UP
NOJIMA SFRP2 TARGETS UP
CHEN HOXA5 TARGETS 6HR UP
MISSIAGLIA REGULATED BY METHYLATION UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
LEONARD HYPOXIA
DORN ADENOVIRUS INFECTION 32HR DN
CROONQUIST STROMAL STIMULATION UP
LEE LIVER CANCER MYC TGFA UP
HALMOS CEBPA TARGETS UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D UP
BOYLAN MULTIPLE MYELOMA C DN
CHANDRAN METASTASIS DN
SIMBULAN UV RESPONSE NORMAL UP
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
DORN ADENOVIRUS INFECTION 12HR UP
MAHADEVAN RESPONSE TO MP470 DN
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
HARRIS HYPOXIA
NETPATH KIT RECEPTOR PATHWAY UP
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
TURASHVILI BREAST DUCTAL CARCINOMA VS DUCTAL NORMAL DN
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
SEIKE LUNG CANCER POOR SURVIVAL
BIOCARTA CYTOKINE PATHWAY
AMIT EGF RESPONSE 20 HELA
BASSO CD40 SIGNALING UP
KAN RESPONSE TO ARSENIC TRIOXIDE
TIAN TNF SIGNALING NOT VIA NFKB
NAGASHIMA NRG1 SIGNALING UP
MARZEC IL2 SIGNALING UP
SOUCEK MYC TARGETS
BIOCARTA PPARA PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
ZERBINI RESPONSE TO SULINDAC UP
BILBAN B CLL LPL DN
WANG ESOPHAGUS CANCER VS NORMAL UP
GENTILE UV LOW DOSE DN
MAHADEVAN RESPONSE TO MP470 UP
FERRARI RESPONSE TO FENRETINIDE UP
MIZUKAMI HYPOXIA DN
SHAFFER IRF4 MULTIPLE MYELOMA PROGRAM
BILD HRAS ONCOGENIC SIGNATURE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
WANG ESOPHAGUS CANCER PROGRESSION UP
WU HBX TARGETS 1 UP
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
AMIT EGF RESPONSE 60 HELA
BERENJENO TRANSFORMED BY RHOA FOREVER DN
MARKS HDAC TARGETS DN
CHEN HOXA5 TARGETS 9HR UP
DAZARD UV RESPONSE CLUSTER G2
WANG RECURRENT LIVER CANCER DN
AMIT SERUM RESPONSE 40 MCF10A
SEKI INFLAMMATORY RESPONSE LPS UP
HELLER HDAC TARGETS SILENCED BY METHYLATION UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
HELLER SILENCED BY METHYLATION DN
BIERIE INFLAMMATORY RESPONSE TGFB1
ENGELMANN CANCER PROGENITORS UP
BUYTAERT PHOTODYNAMIC THERAPY STRESS UP
SENESE HDAC1 AND HDAC2 TARGETS UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D DN
WANG METHYLATED IN BREAST CANCER
XU HGF TARGETS INDUCED BY AKT1 6HR
AMIT EGF RESPONSE 240 HELA
ONDER CDH1 TARGETS 2 DN
SENESE HDAC1 TARGETS UP
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
KIM WT1 TARGETS UP
SENESE HDAC3 TARGETS UP
ONDER CDH1 TARGETS 1 DN
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
KOBAYASHI EGFR SIGNALING 6HR DN
BROWNE HCMV INFECTION 1HR UP
DORSAM HOXA9 TARGETS DN
HESS TARGETS OF HOXA9 AND MEIS1 DN
DASU IL6 SIGNALING UP
ELVIDGE HYPOXIA BY DMOG UP
AMIT EGF RESPONSE 120 MCF10A
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
GOUYER TATI TARGETS UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
ZUCCHI METASTASIS DN
LU IL4 SIGNALING
BRUECKNER TARGETS OF MIRLET7A3 UP
SMID BREAST CANCER BASAL UP
PRAMOONJAGO SOX4 TARGETS UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
LU TUMOR ENDOTHELIAL MARKERS UP
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
yersinia enterocolitica wap bl6listeria monocytogenesstreptococcus pneumoniae tigr4GeneSet Name
0.00277 0.00163 0.00001GERY_CEBP_TARGETS
0.00024 0.00000 0.00001NETPATH_IL_1_PATHWAY_UP
0.04029 0.03270 0.00000NETPATH_EGFR1_PATHWAY_UP
0.01769 0.00068 0.07061NETPATH_IL_2_PATHWAY_UP
0.00016 0.00098 0.00685NETPATH_IL_4_PATHWAY_UP
0.00145 0.00001 0.01938NETPATH_IL_4_PATHWAY_DOWN
0.12479 0.00321 0.01481NCI_LYSOPHOSPHOLIPID_PATHWAY
0.00024 0.00007 0.00000NETPATH_TNF_ALPHA_PATHWAY_DOWN
0.00000 0.00553 0.00810NETPATH_IL_3_PATHWAY_UP
0.00000 0.00233 0.00000NETPATH_IL_6_PATHWAY_UP
0.02712 0.00007 0.00002NETPATH_IL_5_PATHWAY_UP
0.00000 0.00023 0.00058GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00113 0.00046 0.00006MAHAJAN_RESPONSE_TO_IL1A_UP
0.02833 0.06578 0.08490LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.01495 0.01117 0.00000VANHARANTA_UTERINE_FIBROID_DN
0.02433 0.00900 0.00051CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.02279 0.06346 0.00000CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.05734 0.09679 0.00292TENEDINI_MEGAKARYOCYTE_MARKERS
0.04571 0.00437 0.00796LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00427 0.04054 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00011 0.00000 0.15403LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.12188 0.19970 0.00958BASAKI_YBX1_TARGETS_DN
0.03142 0.00043 0.02026LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.15209 0.19899 0.02206ODONNELL_TFRC_TARGETS_UP
0.00923 0.00023 0.00000ELVIDGE_HYPOXIA_UP
0.06527 0.00481 0.19106GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.05090 0.01417 0.08439IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.01474 0.00068 0.00000AMIT_EGF_RESPONSE_40_HELA
0.00623 0.09197 0.00009NETPATH_IL_7_PATHWAY_UP
0.19093 0.15820 0.00224YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.02652 0.13545 0.04977MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.00024 0.00000 0.00077THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.01109 0.00008 0.07760TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.00998 0.00030 0.00024TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.00000 0.00001 0.00741HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.19614 0.00579 0.00001DORN_ADENOVIRUS_INFECTION_48HR_DN
0.02167 0.07054 0.00022GENTILE_UV_RESPONSE_CLUSTER_D1
0.00045 0.00736 0.02561KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.17038 0.19588 0.00691AMIT_EGF_RESPONSE_240_MCF10A
0.08327 0.04416 0.09859OSADA_ASCL1_TARGETS_DN
0.00000 0.02234 0.00000AMIT_SERUM_RESPONSE_60_MCF10A
0.00646 0.01422 0.00090DUTTA_APOPTOSIS_VIA_NFKB
0.19398 0.00178 0.00000GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.03190 0.04616 0.08033KRISHNAN_FURIN_TARGETS_UP
0.00000 0.00199 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.06210 0.00003 0.11158RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.01510 0.00011 0.00001SEMENZA_HIF1_TARGETS
0.06500 0.05773 0.00004NCI_NFAT_TFPATHWAY
0.00000 0.00000 0.00172ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00150 0.00011 0.00000ONDER_CDH1_TARGETS_3_DN
0.00200 0.00000 0.00000GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.17352 0.17670 0.14203SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN
0.00077 0.02592 0.00000AMIT_EGF_RESPONSE_120_HELA
0.19623 0.09424 0.18502DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.05455 0.17317 0.05739BIOCARTA_RANKL_PATHWAY
0.08508 0.06178 0.06462VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
0.10871 0.01127 0.05863NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.06926 0.00186 0.00002WINTER_HYPOXIA_METAGENE
0.00049 0.00000 0.18322MCLACHLAN_DENTAL_CARIES_UP
0.08717 0.01225 0.00000DAZARD_RESPONSE_TO_UV_NHEK_UP
0.09603 0.01700 0.00103GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.00882 0.09674 0.07628NEWMAN_ERCC6_TARGETS_UP
0.00519 0.01078 0.00114SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.00017 0.00004 0.00000PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.00409 0.00001 0.00001GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.00000 0.00001 0.01424FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00381 0.02021 0.09181LEE_LIVER_CANCER_E2F1_UP
0.15470 0.00125 0.01378TAVOR_CEBPA_TARGETS_UP
0.00000 0.00001 0.09452GAURNIER_PSMD4_TARGETS
0.04808 0.03199 0.00028SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.00000 0.00000 0.05005ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.10121 0.05101 0.04615BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
0.00141 0.02216 0.00000GESERICK_TERT_TARGETS_DN
0.14589 0.05923 0.05146NETPATH_TGFBETA_RECEPTOR_PATHWAY_DOWN
0.00013 0.00040 0.00000AMIT_SERUM_RESPONSE_120_MCF10A
0.06014 0.02059 0.00000BROWNE_HCMV_INFECTION_2HR_UP
0.09507 0.00441 0.00000DORN_ADENOVIRUS_INFECTION_24HR_DN
0.03490 0.14854 0.15591ZIRN_TRETINOIN_RESPONSE_UP
0.00757 0.00002 0.00000SESTO_RESPONSE_TO_UV_C3
0.00001 0.00000 0.01022VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.07508 0.15374 0.00000AMIT_EGF_RESPONSE_40_MCF10A
0.01123 0.00001 0.00015BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.00179 0.00027 0.03793GEISS_RESPONSE_TO_DSRNA_UP
0.00514 0.00032 0.00170GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.08860 0.14599 0.00000NCI_P53DOWNSTREAMPATHWAY
0.05337 0.16339 0.09063CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_RPL6_RPL30_RPS13_CHUK_DDX3X_NFKB2_NFKBIB_REL_IKBKG_NFKB1_MAP3K8_RELB_GLG1_NFKBIA_RELA_TNIP2__GTF2I
0.00018 0.00125 0.02569ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.00000 0.00054 0.00001TIAN_TNF_SIGNALING_VIA_NFKB
0.00797 0.12558 0.00966NCI_HIF2PATHWAY
0.01085 0.05480 0.19116MURAKAMI_UV_RESPONSE_1HR_DN
0.05500 0.00488 0.00028GENTILE_UV_LOW_DOSE_UP
0.00139 0.02848 0.01752LEE_LIVER_CANCER_HEPATOBLAST
0.00000 0.00001 0.00000NAGASHIMA_EGF_SIGNALING_UP
0.09096 0.15378 0.00068KRIGE_AMINO_ACID_DEPRIVATION
0.00000 0.01523 0.00000AMIT_EGF_RESPONSE_60_MCF10A
0.03435 0.00031 0.00038HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.07223 0.00045 0.00381RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.00172 0.02668 0.00000NOJIMA_SFRP2_TARGETS_UP
0.03187 0.00069 0.00007CHEN_HOXA5_TARGETS_6HR_UP
0.00468 0.00001 0.05746MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.05054 0.00015 0.00812SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00000 0.00001 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.08551 0.00328 0.00001LEONARD_HYPOXIA
0.13670 0.01095 0.00000DORN_ADENOVIRUS_INFECTION_32HR_DN
0.04761 0.05925 0.00000CROONQUIST_STROMAL_STIMULATION_UP
0.08847 0.00938 0.14214LEE_LIVER_CANCER_MYC_TGFA_UP
0.00185 0.01542 0.00000HALMOS_CEBPA_TARGETS_UP
0.00023 0.00001 0.12061TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.01814 0.15341 0.00574BOYLAN_MULTIPLE_MYELOMA_C_DN
0.18204 0.06255 0.00003CHANDRAN_METASTASIS_DN
0.11226 0.04183 0.00048SIMBULAN_UV_RESPONSE_NORMAL_UP
0.01516 0.00298 0.00068GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.00709 0.02117 0.00004DORN_ADENOVIRUS_INFECTION_12HR_UP
0.00031 0.01146 0.00000MAHADEVAN_RESPONSE_TO_MP470_DN
0.07134 0.07558 0.07890CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.00250 0.00000 0.00000HARRIS_HYPOXIA
0.00062 0.05671 0.00001NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.00700 0.00000 0.09743FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.08439 0.12603 0.10905TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.03842 0.08045 0.00000CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.05961 0.00000 0.00002DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.00425 0.00438 0.05865SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.00000 0.02298 0.10346BIOCARTA_CYTOKINE_PATHWAY
0.16753 0.02894 0.00019AMIT_EGF_RESPONSE_20_HELA
0.00000 0.00020 0.01887BASSO_CD40_SIGNALING_UP
0.04922 0.00399 0.00024KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.01664 0.01298 0.00000TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.00002 0.00045 0.00000NAGASHIMA_NRG1_SIGNALING_UP
0.00016 0.00507 0.01084MARZEC_IL2_SIGNALING_UP
0.00000 0.09270 0.02991SOUCEK_MYC_TARGETS
0.00493 0.13158 0.01946BIOCARTA_PPARA_PATHWAY
0.00017 0.00142 0.04093TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.13677 0.05033 0.00038ZERBINI_RESPONSE_TO_SULINDAC_UP
0.02307 0.01132 0.00001BILBAN_B_CLL_LPL_DN
0.11437 0.17037 0.16764WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.06577 0.00587 0.00037GENTILE_UV_LOW_DOSE_DN
0.00025 0.00004 0.05724MAHADEVAN_RESPONSE_TO_MP470_UP
0.00508 0.06128 0.00024FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.08446 0.14691 0.11063MIZUKAMI_HYPOXIA_DN
0.01088 0.00105 0.02086SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.00208 0.00000 0.00000BILD_HRAS_ONCOGENIC_SIGNATURE
0.00000 0.00001 0.13850LIANG_SILENCED_BY_METHYLATION_2
0.05660 0.00016 0.00000DAUER_STAT3_TARGETS_UP
0.14989 0.19686 0.03617WANG_ESOPHAGUS_CANCER_PROGRESSION_UP
0.00703 0.08533 0.00585WU_HBX_TARGETS_1_UP
0.16114 0.03814 0.00000ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.02663 0.02795 0.00000AMIT_EGF_RESPONSE_60_HELA
0.19546 0.03353 0.00046BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.10363 0.01133 0.15432MARKS_HDAC_TARGETS_DN
0.01506 0.00000 0.00003CHEN_HOXA5_TARGETS_9HR_UP
0.11521 0.04745 0.00000DAZARD_UV_RESPONSE_CLUSTER_G2
0.11334 0.03753 0.01420WANG_RECURRENT_LIVER_CANCER_DN
0.00000 0.00799 0.00000AMIT_SERUM_RESPONSE_40_MCF10A
0.00000 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.13166 0.06392 0.16607HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
0.00810 0.00097 0.00000GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00369 0.00060 0.00250CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.00000 0.00000 0.00001ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.04866 0.07386 0.06732HELLER_SILENCED_BY_METHYLATION_DN
0.07716 0.05971 0.00416BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.10293 0.00527 0.05987ENGELMANN_CANCER_PROGENITORS_UP
0.09654 0.00000 0.00109BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
0.02769 0.00023 0.05989SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.08400 0.00310 0.15405TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.00217 0.17968 0.00000WANG_METHYLATED_IN_BREAST_CANCER
0.01150 0.00954 0.05262XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.01085 0.00272 0.15294AMIT_EGF_RESPONSE_240_HELA
0.00065 0.00554 0.10479ONDER_CDH1_TARGETS_2_DN
0.08354 0.00009 0.08992SENESE_HDAC1_TARGETS_UP
0.00080 0.00000 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.01612 0.01564 0.00001KIM_WT1_TARGETS_UP
0.07491 0.00256 0.11682SENESE_HDAC3_TARGETS_UP
0.07697 0.00003 0.00114ONDER_CDH1_TARGETS_1_DN
0.00000 0.00007 0.00000UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.12191 0.01417 0.00001KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.13313 0.06927 0.00980BROWNE_HCMV_INFECTION_1HR_UP
0.05410 0.00116 0.05686DORSAM_HOXA9_TARGETS_DN
0.00000 0.00001 0.00000HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.01073 0.00595 0.00007DASU_IL6_SIGNALING_UP
0.01114 0.00142 0.00000ELVIDGE_HYPOXIA_BY_DMOG_UP
0.02376 0.00423 0.00000AMIT_EGF_RESPONSE_120_MCF10A
0.00024 0.00001 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.01812 0.06660 0.15861GOUYER_TATI_TARGETS_UP
0.00000 0.00001 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.08451 0.00518 0.00000ZUCCHI_METASTASIS_DN
0.00017 0.01517 0.17647LU_IL4_SIGNALING
0.16977 0.00484 0.01685BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.00369 0.14974 0.19757SMID_BREAST_CANCER_BASAL_UP
0.02502 0.01526 0.00000PRAMOONJAGO_SOX4_TARGETS_UP
0.00000 0.00887 0.00000PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.07123 0.06387 0.00069YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.00476 0.05106 0.16737LU_TUMOR_ENDOTHELIAL_MARKERS_UP